Comparaison of 3 Protocols of Ocytocin Administration in C Section
Launched by MONGI SLIM HOSPITAL · Aug 5, 2019
Trial Information
Current as of June 28, 2025
Completed
Keywords
ClinConnect Summary
This study aimed to compare 3 doses of ocytocin in bolus injection and contnious perfusion during C section. these doses determined by: high, intermediate and low doses, were administred to parturients during elective or urgent C section under spinal anesthesia.
The aim was to determine the lowest efficient dose to prevent post partum hemorrage and with the lowest incidence of maternal side effects.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All adult patients scheduled for C section under spinal anesthesia, monofoetal pregnancy, full term
- Exclusion Criteria:
- • necessity of general anesthesia
- • non conscent
About Mongi Slim Hospital
Mongi Slim Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a multidisciplinary approach, the hospital fosters a collaborative environment for researchers and healthcare professionals. By conducting rigorous and ethically sound clinical studies, Mongi Slim Hospital aims to contribute to the development of new therapies and treatment protocols, ensuring that cutting-edge medical advancements are accessible to the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunis, , Tunisia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials